Cargando…
COVID-19 Imaging: What We Know Now and What Remains Unknown
Infection by SARS-CoV-2 virus ranges from asymptomatic to severe and sometimes fatal disease, most frequently the result of acute lung injury. The role of imaging has evolved during the pandemic, initially with CT as alternative and possibly superior test compared to RT-PCR, to a more limited role b...
Autores principales: | Kanne, Jeffrey P., Bai, Harrison, Bernheim, Adam, Chung, Michael, Haramati, Linda B, Kallmes, David F., Little, Brent P., Rubin, Geoffrey D., Sverzellati, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radiological Society of North America
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879709/ https://www.ncbi.nlm.nih.gov/pubmed/33560192 http://dx.doi.org/10.1148/radiol.2021204522 |
Ejemplares similares
-
Hepatitis B Treatment: What We Know Now and What Remains to Be Researched
por: Suk‐Fong Lok, Anna
Publicado: (2018) -
A scoping review of penile implant biofilms—what do we know and what remains unknown?
por: Leong, Joon Yau, et al.
Publicado: (2022) -
Zika Virus on a Spreading Spree: what we now know that was unknown in the 1950’s
por: Basu, Rupsa, et al.
Publicado: (2016) -
Human metapneumovirus - what we know now
por: Shafagati, Nazly, et al.
Publicado: (2018) -
Halogenation in Fungi: What Do We Know and What Remains to Be Discovered?
por: Cochereau, Bastien, et al.
Publicado: (2022)